CA2485494C - Anti-tumour polycyclic carboxamides - Google Patents

Anti-tumour polycyclic carboxamides Download PDF

Info

Publication number
CA2485494C
CA2485494C CA2485494A CA2485494A CA2485494C CA 2485494 C CA2485494 C CA 2485494C CA 2485494 A CA2485494 A CA 2485494A CA 2485494 A CA2485494 A CA 2485494A CA 2485494 C CA2485494 C CA 2485494C
Authority
CA
Canada
Prior art keywords
formula
compound
iii
optionally substituted
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2485494A
Other languages
English (en)
French (fr)
Other versions
CA2485494A1 (en
Inventor
Bruce Charles Baguley
Leslie William Deady
William Alexander Denny
Thomas Rodemann
Michael Leslie Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
La Trobe University
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Trobe University, Auckland Uniservices Ltd filed Critical La Trobe University
Publication of CA2485494A1 publication Critical patent/CA2485494A1/en
Application granted granted Critical
Publication of CA2485494C publication Critical patent/CA2485494C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2485494A 2002-05-15 2003-05-12 Anti-tumour polycyclic carboxamides Expired - Fee Related CA2485494C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS2344 2002-05-15
AUPS2344A AUPS234402A0 (en) 2002-05-15 2002-05-15 Anti-tumour polycyclic carboxamides
PCT/AU2003/000569 WO2003097642A1 (en) 2002-05-15 2003-05-12 Anti-tumour polycyclic carboxamides

Publications (2)

Publication Number Publication Date
CA2485494A1 CA2485494A1 (en) 2003-11-27
CA2485494C true CA2485494C (en) 2011-08-23

Family

ID=3835914

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2485494A Expired - Fee Related CA2485494C (en) 2002-05-15 2003-05-12 Anti-tumour polycyclic carboxamides

Country Status (8)

Country Link
US (2) US7504507B2 (https=)
EP (1) EP1507778B1 (https=)
JP (1) JP2005531563A (https=)
AT (1) ATE546447T1 (https=)
AU (1) AUPS234402A0 (https=)
CA (1) CA2485494C (https=)
NZ (1) NZ537015A (https=)
WO (1) WO2003097642A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS234402A0 (en) * 2002-05-15 2002-06-13 Auckland Uniservices Limited Anti-tumour polycyclic carboxamides
AU2005209845A1 (en) * 2004-01-30 2005-08-18 Chemgenex Pharmaceuticals, Inc. Naphthalimide dosing by N-acetyl transferase genotyping
US20080248134A1 (en) * 2005-05-04 2008-10-09 Auckland Uniservices Limited Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof
CZ304996B6 (cs) 2013-01-17 2015-03-18 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Deriváty helquatů, jejich příprava a použití jako léčiva
CZ307163B6 (cs) 2014-05-29 2018-02-14 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. Helquaty s heteroaromatickými substituenty, jejich příprava a použití jako stabilizátory G-kvadruplexů
WO2017097928A1 (en) * 2015-12-08 2017-06-15 Universität Zu Köln Cpap-tubulin module
CN109265396A (zh) * 2018-09-12 2019-01-25 李玮 多环酰胺化合物的合成新方法与抗癌活性
CN115677691B (zh) * 2022-08-24 2023-08-29 潍坊富邦药业有限公司 一种苯并萘啶酰胺抗癌药sn28049及其类似物的制备方法
CN118852160A (zh) * 2024-09-24 2024-10-29 世华合创生物技术开发(山东)有限公司 一种三环酰胺化合物、制备方法及应用
CN119350330B (zh) * 2024-12-23 2025-03-21 世华合创生物技术开发(山东)有限公司 一种二氮杂三环胺化合物、制备方法及其应用
CN119350329B (zh) * 2024-12-23 2025-03-21 世华合创生物技术开发(山东)有限公司 一种二氮杂三环胺化合物、制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
NZ201084A (en) * 1982-06-25 1985-10-11 New Zealand Dev Finance 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
AUPS234402A0 (en) * 2002-05-15 2002-06-13 Auckland Uniservices Limited Anti-tumour polycyclic carboxamides

Also Published As

Publication number Publication date
WO2003097642A1 (en) 2003-11-27
EP1507778A4 (en) 2006-05-31
JP2005531563A (ja) 2005-10-20
AUPS234402A0 (en) 2002-06-13
EP1507778B1 (en) 2012-02-22
ATE546447T1 (de) 2012-03-15
US7504507B2 (en) 2009-03-17
NZ537015A (en) 2007-06-29
EP1507778A1 (en) 2005-02-23
US20090156630A1 (en) 2009-06-18
US20050245561A1 (en) 2005-11-03
CA2485494A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
US20090156630A1 (en) Anti-tumour polycyclic carboxamides
US5180722A (en) 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US5646159A (en) Water-soluble esters of camptothecin compounds
JP5337104B2 (ja) 可溶化トポイソメラーゼ毒
EP0418099B1 (en) Process of preparation of 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog
AU765128B2 (en) Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
AU2009242279B2 (en) Spiro-indole derivatives for the treatment of parasitic diseases
US20040110782A1 (en) Nitro and amino substituted heterocycles as topoisomerase I targeting agents
EP0436653A1 (en) Synthesis of camptothecin and analogs thereof
US5340817A (en) Method of treating tumors with anti-tumor effective camptothecin compounds
US5227380A (en) Pharmaceutical compositions and methods employing camptothecins
AU2017204748B2 (en) (--)-Huperzine A processes and related compositions and methods of treatment
US6992089B2 (en) Nitro and amino substituted topoisomerase agents
WO1991004260A2 (en) 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
AU2003221640B2 (en) Anti-tumour polycyclic carboxamides
US8410130B2 (en) Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents
ES2401563T3 (es) Derivados de metilendioxibenzo [I]fenantridina usados para tratar el cáncer
PT682030E (pt) Derivados de 8-amino-10-(azabiciclo-alquil)-pirido¬1,2,3-d,e|-¬1,3,4|benzoxadiazina processo para a sua preparacao assim como agentes antibacterianos que contem estes compostos
EP2044078B1 (en) Camptothecin derivatives with antitumor activity
AU640950B2 (en) 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
WO2002030906A1 (en) Anti-tumour compounds
BR112018016968B1 (pt) Composto,composição farmacêutica e uso do mesmo para preparo de um medicamento para tratamento de câncer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140513